NASDAQ : LSTA
Lisata Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.02 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.19M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Lisata Therapeutics, Inc. (LSTA) reported revenue of 100.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 100.00K | 170.00K | 1.00M | |||
| Gross Profit | 100.00K | 170.00K | 1.00M | |||
| Selling, General & Admin | 11.65M | 10.43M | 12.07M | 12.97M | 14.14M | 11.47M |
| Research & Development | 4.88M | 7.95M | 11.33M | 12.73M | 13.07M | 17.58M |
| Operating Expenses | 16.53M | 18.38M | 23.41M | 25.71M | 27.21M | 29.05M |
| Operating Income | -16.43M | -18.21M | -22.41M | -25.71M | -27.21M | -29.05M |
| Interest & Investment Income | 523.00K | 806.00K | 1.88M | 2.72M | 1.05M | 151.00K |
| Other Non Operating Income (Expenses) | 1.03M | -45.00K | -157.00K | -86.00K | -55.00K | -75.00K |
| EBT Excluding Unusual Items | -14.87M | -17.45M | -20.68M | -23.07M | -26.21M | -28.97M |
| Gain (Loss) on Sale of Assets | -138.00K | -100.00K | -100.00K | -100.00K | -100.00K | |
| Pretax Income | -15.01M | -17.55M | -20.78M | -23.17M | -56.70M | -28.97M |
| Income Tax Expense | -387.00K | -962.00K | -798.00K | -2.33M | -2.48M | -1.51M |
| Earnings From Continuing Operations | -14.62M | -16.59M | -19.98M | -20.84M | -54.23M | -27.47M |
| Net Income to Company | -14.62M | -16.59M | -19.98M | -20.84M | -54.23M | -27.47M |
| Net Income | -14.62M | -16.59M | -19.98M | -20.84M | -54.23M | -27.47M |
| Net Income to Common | -14.62M | -16.59M | -19.98M | -20.84M | -54.23M | -27.47M |
| Shares Outstanding (Basic) | 8.91M | 8.69M | 8.33M | 8.07M | 5.18M | 3.69M |
| Shares Outstanding (Diluted) | 8.91M | 8.69M | 8.33M | 8.07M | 5.18M | 3.69M |
| EPS (Basic) | -1.64 | -1.91 | -2.40 | -2.58 | -10.47 | -7.45 |
| EPS (Diluted) | -1.64 | -1.91 | -2.40 | -2.58 | -10.47 | -7.45 |
| Free Cash Flow | -12.32M | -15.98M | -19.36M | -20.03M | -21.45M | -22.30M |
| Free Cash Flow Per Share | -1.38 | -1.84 | -2.32 | -2.48 | -4.14 | -6.05 |
| Gross Margin | 100.00% | 100.00% | 100.00% | |||
| Operating Margin | -16,426.00% | -10,711.18% | -2,240.90% | |||
| Profit Margin | -14,621.00% | -9,756.47% | -1,998.50% | |||
| Free Cash Flow Margin | -12,323.00% | -9,398.24% | -1,935.60% | |||
| EBITDA | -16.36M | -18.06M | -22.23M | -25.52M | -27.14M | -29.00M |
| D&A For EBITDA | 64.00K | 146.00K | 174.00K | 189.00K | 69.00K | 55.00K |
| EBIT | -16.43M | -18.21M | -22.41M | -25.71M | -27.21M | -29.05M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 10.44M | 15.96M | 16.21M | 22.59M | 32.15M | 24.65M |
| Short-Term Investments | 15.04M | 27.94M | 37.07M | 70.32M | ||
| Cash & Short-Term Investments | 10.44M | 15.96M | 31.25M | 50.53M | 69.23M | 94.97M |
| Accounts Receivable | 900.00K | |||||
| Other Receivables | 200.00K | 700.00K | 600.00K | 700.00K | ||
| Receivables | 200.00K | 700.00K | 1.50M | 700.00K | ||
| Prepaid Expenses | 370.00K | 1.05M | 1.83M | 3.39M | 1.95M | 1.21M |
| Total Current Assets | 11.01M | 17.70M | 34.58M | 53.92M | 71.88M | 96.18M |
| Property, Plant & Equipment | 14.00K | 18.00K | 210.00K | 483.00K | 783.00K | 786.00K |
| Other Intangible Assets | 192.00K | 263.00K | 334.00K | |||
| Other Long-Term Assets | 23.00K | 22.00K | 24.00K | 41.00K | 40.00K | |
| Total Assets | 11.03M | 17.74M | 35.00M | 54.69M | 73.03M | 97.01M |
| Accounts Payable | 836.00K | 1.02M | 1.28M | 2.42M | 2.65M | 1.93M |
| Accrued Expenses | 2.05M | 2.05M | 4.19M | 4.00M | 3.55M | 2.36M |
| Current Portion of Leases | 137.00K | 168.00K | 180.00K | 229.00K | ||
| Other Current Liabilities | 100.00K | |||||
| Total Current Liabilities | 2.99M | 3.07M | 5.61M | 6.59M | 6.38M | 4.52M |
| Long-Term Leases | 137.00K | 305.00K | 485.00K | |||
| Other Long-Term Liabilities | 50.00K | 72.00K | 72.00K | 73.00K | 22.00K | |
| Total Liabilities | 3.04M | 3.14M | 5.68M | 6.80M | 6.71M | 5.01M |
| Common Stock | 9.00K | 9.00K | 8.00K | 8.00K | 8.00K | 4.00K |
| Additional Paid-In Capital | 581.03M | 580.24M | 578.42M | 576.97M | 574.55M | 546.04M |
| Retained Earnings | -572.07M | -564.65M | -548.07M | -528.08M | -507.24M | -453.02M |
| Treasury Stock | -708.00K | -708.00K | -708.00K | -708.00K | -708.00K | -708.00K |
| Comprehensive Income & Other | -17.00K | -37.00K | -81.00K | -42.00K | -29.00K | -70.00K |
| Total Common Equity | 8.24M | 14.86M | 29.57M | 48.15M | 66.58M | 92.25M |
| Minority Interest | -254.00K | -254.00K | -254.00K | -254.00K | -254.00K | -254.00K |
| Shareholders' Equity | 7.99M | 14.60M | 29.32M | 47.89M | 66.32M | 92.00M |
| Total Liabilities & Equity | 11.03M | 17.74M | 35.00M | 54.69M | 73.03M | 97.01M |
| Total Debt | 137.00K | 305.00K | 485.00K | 714.00K | ||
| Net Cash (Debt) | 10.44M | 15.96M | 31.11M | 50.23M | 68.74M | 94.26M |
| Net Cash Per Share | 1.17 | 1.84 | 3.73 | 6.22 | 13.27 | 25.56 |
| Filing Date Shares Outstanding | 9.01M | 9.03M | 27.70M | 8.31M | 8.00M | 4.04M |
| Total Common Shares Outstanding | 9.12M | 8.83M | 8.41M | 8.15M | 7.87M | 3.99M |
| Working Capital | 8.03M | 14.63M | 28.96M | 47.33M | 65.49M | 91.66M |
| Book Value Per Share | 0.90 | 1.68 | 3.52 | 5.91 | 8.46 | 23.14 |
| Tangible Book Value | 8.24M | 14.86M | 29.38M | 47.88M | 66.24M | 92.25M |
| Tangible Book Value Per Share | 0.90 | 1.68 | 3.49 | 5.88 | 8.42 | 23.14 |
| Machinery | 494.00K | 494.00K | 589.00K | 589.00K | 614.00K | 340.00K |
| Leasehold Improvements | 72.00K | 72.00K | 99.00K | 90.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -14.62M | -16.59M | -19.98M | -20.84M | -54.23M | -27.47M |
| Depreciation & Amortization | 64.00K | 146.00K | 174.00K | 189.00K | 69.00K | 55.00K |
| Loss (Gain) From Sale of Assets | 3.00K | |||||
| Asset Writedown & Restructuring Costs | 127.00K | 127.00K | 30.39M | |||
| Loss (Gain) From Sale of Investments | -14.00K | -75.00K | -455.00K | -960.00K | 788.00K | 2.51M |
| Loss (Gain) on Equity Investments | 130.00K | |||||
| Stock-Based Compensation | 1.03M | 1.23M | 1.65M | 2.04M | 2.64M | 2.00M |
| Provision & Write-off of Bad Debts | 500.00K | 500.00K | ||||
| Change in Accounts Receivable | 2.00K | 401.00K | -900.00K | |||
| Change in Accounts Payable | -1.37M | -2.57M | -995.00K | 88.00K | -223.00K | 1.25M |
| Change in Other Net Operating Assets | 1.95M | 882.00K | 1.02M | -550.00K | -608.00K | -603.00K |
| Operating Cash Flow | -12.32M | -15.95M | -19.36M | -20.03M | -21.17M | -22.25M |
| Capital Expenditures | -28.00K | -285.00K | -60.00K | |||
| Cash Acquisitions | -3.32M | |||||
| Investment in Securities | 5.15M | 15.11M | 13.23M | 10.10M | 32.52M | -54.84M |
| Investing Cash Flow | 5.15M | 15.09M | 13.23M | 10.10M | 28.91M | -54.90M |
| Issuance of Common Stock | 927.00K | 852.00K | 68.00K | 476.00K | 43.00K | 85.52M |
| Repurchase of Common Stock | -159.00K | -253.00K | -274.00K | -91.00K | -267.00K | -248.00K |
| Financing Cash Flow | 768.00K | 599.00K | -206.00K | 385.00K | -224.00K | 85.28M |
| Foreign Exchange Rate Adjustments | 13.00K | 11.00K | -55.00K | -16.00K | -10.00K | |
| Net Cash Flow | -6.39M | -253.00K | -6.38M | -9.56M | 7.51M | 8.13M |
| Free Cash Flow | -12.32M | -15.98M | -19.36M | -20.03M | -21.45M | -22.30M |
| Free Cash Flow Margin | -12,323.00% | -9,398.24% | -1,935.60% | |||
| Free Cash Flow Per Share | -1.38 | -1.84 | -2.32 | -2.48 | -4.14 | -6.05 |
| Levered Free Cash Flow | -8.10M | -10.85M | -13.07M | -14.36M | -14.11M | -15.45M |
| Unlevered Free Cash Flow | -8.10M | -10.85M | -13.07M | -14.36M | -14.11M | -15.45M |
| Change in Working Capital | 586.00K | -1.29M | -873.00K | -462.00K | -831.00K | 647.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 9.19M | 16.41M | 25.02M | 22.22M | 19.89M | 50.31M |
| Enterprise Value | -1.25M | -2.85M | -10.91M | -32.08M | -55.35M | -49.74M |
| Last Close Price | 1.02 | 1.86 | 2.98 | 2.73 | 2.53 | 12.62 |
| PS Ratio | 91.91 | 96.51 | 25.02 | |||
| PB Ratio | 1.13 | 1.12 | 0.85 | 0.46 | 0.30 | 0.55 |
| P/TBV Ratio | 1.11 | 1.10 | 0.85 | 0.46 | 0.30 | 0.55 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | ||
| Net Debt / Equity Ratio | -1.31 | -1.09 | -1.06 | -1.05 | -1.04 | -1.02 |
| Net Debt / EBITDA Ratio | 0.64 | 0.88 | 1.40 | 1.97 | 2.53 | 3.25 |
| Net Debt / FCF Ratio | 0.85 | 1.00 | 1.61 | 2.51 | 3.20 | 4.23 |
| Asset Turnover | 0.01 | 0.01 | 0.02 | |||
| Quick Ratio | 3.56 | 5.42 | 5.83 | 7.67 | 10.96 | 21.00 |
| Current Ratio | 3.69 | 5.76 | 6.16 | 8.18 | 11.26 | 21.27 |
| Return on Equity (ROE) | -101.66% | -75.53% | -51.77% | -36.49% | -68.50% | -44.21% |
| Return on Assets (ROA) | -56.74% | -43.15% | -31.23% | -25.16% | -20.00% | -27.30% |
| Return on Capital Employed (ROCE) | -204.30% | -124.10% | -76.20% | -53.40% | -40.80% | -31.40% |
| Earnings Yield | -160.82% | -101.09% | -79.89% | -93.79% | -272.69% | -54.59% |
| FCF Yield | -134.07% | -97.38% | -77.37% | -90.15% | -107.90% | -44.33% |
| Buyback Yield / Dilution | -5.10% | -4.30% | -3.17% | -55.85% | -40.46% | -258.29% |